Header Logo

Oren Schaefer

Concepts (63)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pneumonia
2
2005
270
0.220
Why?
Mycobacterium avium Complex
1
2003
3
0.220
Why?
Suppuration
1
2003
11
0.220
Why?
Mycobacterium avium-intracellulare Infection
1
2003
8
0.220
Why?
Respiratory Tract Infections
1
2003
80
0.200
Why?
Bacterial Infections
1
2003
138
0.190
Why?
Cough
1
2003
182
0.180
Why?
Angioedemas, Hereditary
1
2010
5
0.090
Why?
Complement C1 Inhibitor Protein
1
2010
6
0.090
Why?
Complement Inactivating Agents
1
2010
13
0.090
Why?
Severity of Illness Index
2
2005
1450
0.080
Why?
Mianserin
1
2005
3
0.060
Why?
Oxazolidinones
1
2005
15
0.060
Why?
Serotonin Syndrome
1
2005
9
0.060
Why?
Acetamides
1
2005
13
0.060
Why?
Citalopram
1
2005
17
0.060
Why?
Triage
1
2005
110
0.060
Why?
Urticaria
1
2004
7
0.060
Why?
Antidepressive Agents
1
2005
229
0.060
Why?
Hypothermia, Induced
1
2004
41
0.060
Why?
Cold Temperature
1
2004
51
0.050
Why?
Patient Admission
1
2005
185
0.050
Why?
Immunocompetence
1
2003
21
0.050
Why?
Bronchoscopy
1
2003
64
0.050
Why?
Aortic Valve
1
2004
169
0.050
Why?
Coronary Artery Bypass
1
2004
274
0.050
Why?
Heart Valve Prosthesis Implantation
1
2004
154
0.050
Why?
Intensive Care Units
1
2005
449
0.050
Why?
Radiography
1
2003
510
0.050
Why?
Diagnosis, Differential
1
2003
904
0.040
Why?
Middle Aged
4
2005
16260
0.040
Why?
Chronic Disease
1
2003
736
0.040
Why?
Anti-Bacterial Agents
1
2005
724
0.040
Why?
Female
5
2010
30896
0.040
Why?
Adult
3
2010
15770
0.030
Why?
Aged
3
2005
13343
0.030
Why?
Humans
6
2010
59476
0.030
Why?
Male
4
2010
27562
0.030
Why?
Adolescent
1
2003
5917
0.020
Why?
Retrospective Studies
1
2003
6008
0.020
Why?
Ultrafiltration
1
2010
11
0.020
Why?
Cross-Over Studies
1
2010
143
0.020
Why?
Infusions, Intravenous
1
2010
169
0.020
Why?
Nanotechnology
1
2010
128
0.020
Why?
Analysis of Variance
1
2010
576
0.020
Why?
Proportional Hazards Models
1
2010
673
0.020
Why?
Double-Blind Method
1
2010
670
0.020
Why?
Acute Disease
1
2010
658
0.020
Why?
Linezolid
1
2005
10
0.020
Why?
Protein Synthesis Inhibitors
1
2005
25
0.020
Why?
Drug Synergism
1
2005
132
0.020
Why?
Bone Marrow Transplantation
1
2005
133
0.020
Why?
Transplantation, Homologous
1
2005
233
0.020
Why?
Urinary Tract Infections
1
2005
76
0.010
Why?
Community-Acquired Infections
1
2005
87
0.010
Why?
Rewarming
1
2004
7
0.010
Why?
Leukemia, Myeloid, Acute
1
2005
162
0.010
Why?
Sensitivity and Specificity
1
2005
1094
0.010
Why?
Pilot Projects
1
2005
922
0.010
Why?
Child
1
2010
4308
0.010
Why?
Risk Assessment
1
2005
1914
0.010
Why?
Aged, 80 and over
1
2005
5098
0.010
Why?
United States
1
2005
7520
0.010
Why?
Schaefer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (63)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_